142 related articles for article (PubMed ID: 2487253)
21. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
[TBL] [Abstract][Full Text] [Related]
22. Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement.
Hervé P; Cahn JY; Flesch M; Plouvier E; Racadot E; Noir A; Couteret Y; Goldstein G; Bernard A; Lenys R
Blood; 1987 Feb; 69(2):388-93. PubMed ID: 3542078
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
Heit W; Bunjes D; Wiesneth M; Schmeiser T; Arnold R; Hale G; Waldmann H; Heimpel H
Br J Haematol; 1986 Nov; 64(3):479-86. PubMed ID: 3539172
[TBL] [Abstract][Full Text] [Related]
24. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.
Prentice HG; Blacklock HA; Janossy G; Gilmore MJ; Price-Jones L; Tidman N; Trejdosiewicz LK; Skeggs DB; Panjwani D; Ball S
Lancet; 1984 Mar; 1(8375):472-6. PubMed ID: 6142207
[TBL] [Abstract][Full Text] [Related]
25. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.
Hartwig UF; Robbers M; Wickenhauser C; Huber C
Blood; 2002 Apr; 99(8):3041-9. PubMed ID: 11929798
[TBL] [Abstract][Full Text] [Related]
26. Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion.
Wagner JE; Donnenberg AD; Noga SJ; Wiley JM; Yeager AM; Vogelsang GB; Hess AD; Santos GW
Exp Hematol; 1988 Mar; 16(3):206-12. PubMed ID: 3257446
[TBL] [Abstract][Full Text] [Related]
27. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
28. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
[TBL] [Abstract][Full Text] [Related]
29. Purging of T-lymphocytes with magnetic affinity colloid.
Yau JC; Reading CL; Thomas MW; Davaraj BM; Tindle SE; Jagannath S; Dicke KA
Exp Hematol; 1990 Mar; 18(3):219-22. PubMed ID: 2303117
[TBL] [Abstract][Full Text] [Related]
30. Immunomagnetic depletion of CD6+ cells from bone marrow and peripheral blood.
Egeland T; Albrechtsen D; Martin PJ; Hansen JA
Bone Marrow Transplant; 1990 Mar; 5(3):193-8. PubMed ID: 1970490
[TBL] [Abstract][Full Text] [Related]
31. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
32. Antilymphocytic antibodies and marrow transplantation. XIV. Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathways.
Thierfelder S; Mysliwietz J; Hoffmann-Fezer G; Kummer U
Blood; 1991 May; 77(10):2285-91. PubMed ID: 2029584
[TBL] [Abstract][Full Text] [Related]
33. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
[No Abstract] [Full Text] [Related]
34. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
Champlin R
Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
[TBL] [Abstract][Full Text] [Related]
35. Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.
Mysliwietz J; Thierfelder S
Blood; 1992 Nov; 80(10):2661-7. PubMed ID: 1358260
[TBL] [Abstract][Full Text] [Related]
36. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
Soiffer RJ; Ritz J
Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
[TBL] [Abstract][Full Text] [Related]
37. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.
Weijtens M; van Spronsen A; Hagenbeek A; Braakman E; Martens A
Hum Gene Ther; 2002 Jan; 13(2):187-98. PubMed ID: 11812276
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Martin PJ; Pei J; Gooley T; Anasetti C; Appelbaum FR; Deeg J; Hansen JA; Nash RA; Petersdorf EW; Storb R; Ghetie V; Schindler J; Vitetta ES
Biol Blood Marrow Transplant; 2004 Aug; 10(8):552-60. PubMed ID: 15282533
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
40. Effect of the YCD3-1 anti-mouse monoclonal on murine GvHD.
OKunewick JP; Kociban DL; Machen LL; Buffo MJ
Cell Transplant; 1993; 2(4):331-7. PubMed ID: 8162275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
